Molecule

LabCorp Venture Fund

In support of LabCorp’s mission to improve health and improve lives, the LabCorp Venture Fund invests in early stage private companies operating in current or strategically adjacent spaces and developing novel solutions to important problems in health and healthcare.

Examples of current and priority investment categories include:

  •  Novel Diagnostic Tests, Platforms, and Services
  •  Biomarkers and Companion Diagnostics
  •  Mobile Health & Digital Diagnostics
  •  Consumer Wellness, Convenience, and Engagement
  •  Data-Driven Drug Development and RWE
  •  Population Health Management and Bioinformatics
  •  Precision Medicine and CDS

40+

Total Direct Investments

$75-150M

Target Fund Size

Series A-B

Typical Initial Investment

Adaptive Biotech
Advanced Animal Diagnostics
Aetion
Ativa Medical
Boston Microfluidics
Emulate
Epic Sciences
Fabric Genomics
Gene Centric
Kiyatec
mc10
Mission Bio
Navigating Cancer
One Ome
Path ai
Precision Digital Health
Recovery Platform
Sandstone Diagnostics
Serimmune
Seventh Sense
Talis